Genomatica has strong results for its GENO BDO biobased process technology regarding overall process performance and production volume to date for bio-based 1,4-butanediol (BDO). Novamont, Genomatica’s first GENO BDO licensee, has officially confirmed that its new industrial plant in Bottrighe, Italy has met all performance guarantees committed to by Genomatica. The guarantees include technical and economic parameters, such as efficiency of converting feedstock sugars to Bio- BDO product and product quality. The process runs as designed, as modeled, and as represented.
The Giro, one of three three-week Grand Tours that include the Tour de France and Vuelta a España, goes green. After the success of the first edition in 2016, the Ride Green project will once again accompany this year’s Giro d’Italia, the competition which for 100 years has showcased sporting competitiveness, the passion of the race fans and the beauty of Italy.
Novamont has exercised its option to acquire the remaining 22% of the share capital of Mater-Biopolymer srl. The Bioplastics firm headquartered in Novara, Northern Italy, acquired in 2014 a majority stake (78%) in the company that operates a resin plant in Lazio, Central Italy, and was a unit of PET resin maker Gruppo Mossi Ghisolfi.
Yesterday in Milan, Italy, started the first edition of the first European Master in Bioeconomy in the Circular economy. To organise it are four Italian universities from North to South (University of Turin, University of Milan Bicocca, University of Bologna and University of Naples Federico II), with the support of three of the main Italian bioeconomy players (Novamont, GFBiochemicals and Science Park of Lodi) and the Italian leading banking Group Intesa Sanpaolo, which is the only financial global partner of the Ellen McArthur Foudation.
“Biotech is becoming increasingly important to the mainstream chemical industry as the demand for more sustainable solutions intensifies. Biotech is especially well-suited to help with some of the industry’s biggest challenges”. To say it – in this exclusive interview with Il Bioeconomista – is Christophe Schilling, founder and CEO of Genomatica, a widely-recognized bioengineering leader for the chemical industry. The San Diego-based biotechnology company develops and licenses bio-based manufacturing processes for the production of intermediate and basic chemicals.
Since being named CEO in May 2009, Christophe Schilling has led Genomatica to widespread recognition as a leader in industrial biotechnology, with a commercialized first process, top-tier licensees, strong investors and an unrivaled string of awards for engineering (Kirkpatrick), science (EPA Presidential Green Chemistry), industry leadership (voted #1 Hottest three years in a row by Biofuels Digest), and company culture (The Scientist as a Best Place to Work). Schilling frequently speaks on industry trends at major conferences and serves as a member of the World Economic Forum Global Agenda Council on Biotechnology.
Interview by Mario Bonaccorso
Mater Biotech, a 100% company owned by Novamont, today proved Genomatica’s revolutionary technology that converts renewable feedstocks into 1,4 butendiol (BDO) at the Grand Opening of its first commercial bio-BDO plant in Bottrighe di Adria (Rovigo, Italy).
Novamont’s bio-based butanediol (BDO) plant in Bottrighe di Adria (Veneto, North-eastern Italy), established as a joint venture (Mater Biotech) with San Diego-based Genomatica and now entirely controlled by the company headquartered in Novara, will come on stream by the end of September. It is a big step forward for the Italian bioeconomy, which is confirmed in its leading role in Europe.
“To pass laws that can make a difference means overcoming the braking action of those who defend and feed the advantageous position, put into practice the good industry and multiply virtuous cases there are in our country. Much of the Italian industry has invested and is investing in the development of new products and “green” technologies, and now considers sustainability as an opportunity rather than a constraint”. Catia Bastioli talks to Il Bioeconomista. In this exclusive interview with the Chief Executive Officer of Novamont, considered as the beacon of Italian bioeconomy, we talk about bioeconomy, circular economy and climate change. A few days before the 4th EU Bioeconomy Stakeholders’ Conference in Utrecht, Bastioli gives us her vision to fully realize in Italy and Europe the new economy based on biological resources, able to create wealth and jobs, starting from the local areas.
Interview by Mario Bonaccorso
We can now drink our espresso and support the bioeconomy and circular economy, thanks to a wholly biodegradable and compostable coffee capsule for espresso machines. Once consumed, it can be collected with the organic waste and processed industrially to become compost. This is the circular economy principle of zero waste, according to which all used products can return to being a resource, with significant environmental benefits. The project – created and used by two of the most popular Italian companies, Novamont and Lavazza – won the Ecomondo Sustainable Development Award 2015 for the category “Waste and Resources”.
Novamont presented last Friday in Milan its new brand identity, in order to enhance and aligning the corporate image of the group.